Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Top Cited Papers
- 7 March 2007
- journal article
- other
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 356 (2) , 323-328
- https://doi.org/10.1016/j.bbrc.2007.02.156
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rapid vascular regrowth in tumors after reversal of VEGF inhibitionJournal of Clinical Investigation, 2006
- Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical OncologyJournal of Clinical Oncology, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Structure and regulation of Kit protein-tyrosine kinase—The stem cell factor receptorBiochemical and Biophysical Research Communications, 2005
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular PermeabilityThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971